Nitrofuran compounds for the treatment of cancer and angiogenesis
US8470815B2 · kind B2 · utility
12Cited by
0References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 7, 2007 |
| Grant date | Jun 25, 2013 |
| Priority date | — |
| Expiry date | Dec 6, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to the synthesis and use of nitrofuran compounds, especially Nifurtimox, as medicaments to treat cancer, especially neuroblastoma, and to inhibit angiogenesis. The invention also provides compositions, unit dosage forms, and kits comprising the compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.